Treace
Ponte Vedra, Florida, United States · Biotechnology, Healthcare, Health Care
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual s
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Ponte Vedra, Florida, United States
- Employees
- Unknown
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (TMCI)
- Website
- http://treace.com
- Company page
Recent activity at Treace
- : SEC 8-K (1.01): On December 17, 2025, Treace Medical Concepts, Inc. entered into two significant Loan Agreements: a Term Loan Agreement with SLR Investment Corp. allowing up to $125 million in borrowing capacity, drawing $60 million upon closing, and a Revolving Loan Agreement with Gemino Healthcare Finance, LLC providing an additional $30 million. The Term Loan includes revenue-based contingencies for further borrowing of up to $65 million. These agreements are crucial for supporting the company's operational and strategic growth initiatives.
- : Treace Medical Concepts, Inc. Launches IntelliGuide™ PSI for Personalized Surgical Treatment of Midfoot Deformities.
- : Guy Guglielmino Joins Treace Medical Concepts, Inc. as Chief Commercial Officer
Employee benefit plans
Treace files 5 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Treace: questions and answers
What does Treace do?
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual s
Where is Treace headquartered?
Treace is headquartered in Ponte Vedra, Florida, United States.
What is the latest news on Treace?
On Dec 16, 2025, SEC 8-K (1.01): On December 17, 2025, Treace Medical Concepts, Inc. entered into two significant Loan Agreements: a Term Loan Agreement with SLR Investment Corp. allowing up to $125 million in borrowing capacity, drawing $60 million upon closing, and a Revolving Loan Agreement with Gemino Healthcare
Is Treace a public company?
Yes. Treace is publicly traded under the ticker TMCI.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy